LIDODERM

Lidoderm Adverse Events Reported to the FDA Over Time

How are Lidoderm adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Lidoderm, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Lidoderm is flagged as the suspect drug causing the adverse event.

Most Common Lidoderm Adverse Events Reported to the FDA

What are the most common Lidoderm adverse events reported to the FDA?

Convulsion	207 (1.46%)
Dizziness	173 (1.22%)
Cardiac Arrest	169 (1.19%)
Drug Ineffective	163 (1.15%)
Loss Of Consciousness	146 (1.03%)
Drug Toxicity	145 (1.02%)
Dyspnoea	124 (.87%)
Overdose	122 (.86%)
Hypotension	121 (.85%)
Pain	119 (.84%)
Drug Interaction	115 (.81%)
	Show More
Nausea	110 (.77%)
Medication Error	98 (.69%)
Bradycardia	94 (.66%)
Anaesthetic Complication	91 (.64%)
Blood Pressure Increased	90 (.63%)
Confusional State	89 (.63%)
Headache	87 (.61%)
Blood Pressure Decreased	85 (.6%)
Tachycardia	85 (.6%)
Anxiety	82 (.58%)
Methaemoglobinaemia	82 (.58%)
Anaphylactic Shock	81 (.57%)
Respiratory Arrest	79 (.56%)
Septic Arthritis Staphylococcal	79 (.56%)
Vomiting	79 (.56%)
Anaphylactic Reaction	78 (.55%)
Drug Hypersensitivity	78 (.55%)
Grand Mal Convulsion	76 (.53%)
Somnolence	71 (.5%)
Syncope	71 (.5%)
Hypoaesthesia	69 (.49%)
Incorrect Route Of Drug Administrat...	69 (.49%)
Coma	67 (.47%)
Heart Rate Increased	65 (.46%)
Hypertension	61 (.43%)
Oedema Peripheral	61 (.43%)
Erythema	60 (.42%)
Off Label Use	59 (.41%)
Post Procedural Complication	59 (.41%)
Agitation	58 (.41%)
Toxic Anterior Segment Syndrome	58 (.41%)
Death	57 (.4%)
Drug Exposure During Pregnancy	56 (.39%)
Weight Decreased	56 (.39%)
Wrong Technique In Drug Usage Proce...	56 (.39%)
Oxygen Saturation Decreased	55 (.39%)
Hypersensitivity	53 (.37%)
Insomnia	53 (.37%)
Malaise	51 (.36%)
Pain In Extremity	51 (.36%)
Palpitations	50 (.35%)
Ventricular Fibrillation	50 (.35%)
Cyanosis	49 (.34%)
Hyperhidrosis	49 (.34%)
Pallor	49 (.34%)
Angioedema	48 (.34%)
Asthenia	48 (.34%)
Cardio-respiratory Arrest	48 (.34%)
Hypertensive Crisis	48 (.34%)
Ventricular Tachycardia	48 (.34%)
Burning Sensation	46 (.32%)
Condition Aggravated	46 (.32%)
Nervousness	46 (.32%)
Pyrexia	46 (.32%)
Tremor	46 (.32%)
Depression	45 (.32%)
Fatigue	45 (.32%)
Urticaria	45 (.32%)
Heart Rate Decreased	44 (.31%)
Pulmonary Oedema	44 (.31%)
Unresponsive To Stimuli	44 (.31%)
Bronchospasm	43 (.3%)
Restlessness	43 (.3%)
Amnesia	42 (.3%)
Procedural Complication	42 (.3%)
Pulse Absent	42 (.3%)
Visual Acuity Reduced	42 (.3%)
Paraesthesia	41 (.29%)
Back Pain	40 (.28%)
Rash	40 (.28%)
Sinus Tachycardia	40 (.28%)
Hypoxia	39 (.27%)
Product Quality Issue	39 (.27%)
Pruritus	39 (.27%)
Abdominal Distension	38 (.27%)
Atrial Fibrillation	38 (.27%)
Fall	38 (.27%)
Gait Disturbance	37 (.26%)
Muscular Weakness	37 (.26%)
Contusion	36 (.25%)
Infection	35 (.25%)
Injection Site Pain	35 (.25%)
Renal Failure Acute	35 (.25%)
Hallucination	34 (.24%)
Pneumonia	34 (.24%)
Speech Disorder	34 (.24%)
Suicidal Ideation	34 (.24%)
Swelling Face	34 (.24%)
Swollen Tongue	34 (.24%)
Vision Blurred	34 (.24%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Lidoderm, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lidoderm is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Lidoderm

What are the most common Lidoderm adverse events reported to the FDA?

Neurological	1144 (8.04%)
Cardiac Arrhythmias	790 (5.55%)
Medication Errors	580 (4.08%)
Respiratory	496 (3.49%)
Cardiac And Vascular Investigations	484 (3.4%)
Epidermal And Dermal Conditions	409 (2.88%)
Procedural And Device Related Injur...	385 (2.71%)
Therapeutic And Nontherapeutic Effe...	372 (2.62%)
Seizures	332 (2.33%)
Infections - Pathogen Unspecified	328 (2.31%)
Allergic Conditions	315 (2.21%)
	Show More
Gastrointestinal Signs	314 (2.21%)
Injuries	252 (1.77%)
Chemical Injury And Poisoning	242 (1.7%)
Anxiety Disorders	207 (1.46%)
Muscle	193 (1.36%)
Movement Disorders	185 (1.3%)
Decreased And Nonspecific Blood Pre...	184 (1.29%)
Vision	177 (1.24%)
Administration Site Reactions	176 (1.24%)
Musculoskeletal And Connective Tiss...	176 (1.24%)
Bacterial Infectious	158 (1.11%)
Metabolic, Nutritional And Blood Ga...	132 (.93%)
Cardiac Disorder Signs	130 (.91%)
Deliria	129 (.91%)
Ocular Infections, Irritations And ...	128 (.9%)
Hematology Investigations	123 (.86%)
Bronchial Disorders	121 (.85%)
Physical Examination Topics	118 (.83%)
Coronary Artery	117 (.82%)
Ocular Neuromuscular	115 (.81%)
Vascular Hypertensive	109 (.77%)
Skin Appendage Conditions	105 (.74%)
Psychiatric	100 (.7%)
Vascular	99 (.7%)
Angiedema And Urticaria	96 (.68%)
Sleep Disorders	96 (.68%)
Lower Respiratory Tract Disorders	94 (.66%)
Fatal Outcomes	93 (.65%)
Headaches	92 (.65%)
Hematological	86 (.6%)
Therapeutic Procedures And Supporti...	85 (.6%)
Joint	83 (.58%)
Upper Respiratory Tract Disorders	82 (.58%)
Oral Soft Tissue Conditions	79 (.56%)
Heart Failures	74 (.52%)
Mental Impairment	74 (.52%)
Product Quality Issues	73 (.51%)
Suicidal And Self-injurious Behavio...	70 (.49%)
Gastrointestinal Motility And Defec...	64 (.45%)
Ocular Structural Change, Deposit A...	63 (.44%)
Eye	62 (.44%)
Body Temperature Conditions	61 (.43%)
Renal Disorders	61 (.43%)
Lifestyle Issues	55 (.39%)
Urinary Tract Signs	53 (.37%)
Mood Disorders	52 (.37%)
Bone Disorders	51 (.36%)
Electrolyte And Fluid Balance Condi...	51 (.36%)
Depressed Mood Disorders	50 (.35%)
Disturbances In Thinking	50 (.35%)
Changes In Physical Activity	48 (.34%)
Neurological, Special Senses And Ps...	48 (.34%)
Tongue Conditions	48 (.34%)
Head And Neck Therapeutic Procedure...	47 (.33%)
Neuromuscular	46 (.32%)
Myocardial	44 (.31%)
Bone And Joint Injuries	43 (.3%)
Obstetric And Gynecological Therape...	43 (.3%)
Retina, Choroid And Vitreous Hemorr...	42 (.3%)
Toxicology And Therapeutic Drug Mon...	41 (.29%)
Hepatobiliary	40 (.28%)
Water, Electrolyte And Mineral	38 (.27%)
Anterior Eye Structural Change, Dep...	37 (.26%)
Dental And Gingival Conditions	37 (.26%)
Hepatic And Hepatobiliary	37 (.26%)
Central Nervous System Vascular	36 (.25%)
Cranial Nerve Disorders	36 (.25%)
Spinal Cord And Nerve Root	34 (.24%)
Appetite And General Nutritional	32 (.23%)
Peripheral Neuropathies	32 (.23%)
Tissue	31 (.22%)
Arteriosclerosis, Stenosis, Vascula...	29 (.2%)
Bone And Joint Therapeutic Procedur...	29 (.2%)
Gastrointestinal Conditions	29 (.2%)
Glucose Metabolism Disorders	29 (.2%)
Immunology And Allergy	29 (.2%)
Viral Infectious	29 (.2%)
Acid-base	27 (.19%)
Skin Vascular Abnormalities	27 (.19%)
White Blood Cell	27 (.19%)
Enzyme	23 (.16%)
Hepatobiliary Therapeutic Procedure...	23 (.16%)
Anemias Nonhemolytic And Marrow Dep...	22 (.15%)
Increased Intracranial Pressure And...	22 (.15%)
Musculoskeletal And Connective Tiss...	22 (.15%)
Vascular Hemorrhagic	21 (.15%)
Encephalopathies	20 (.14%)
Hearing	20 (.14%)
Inner Ear And Viiith Cranial Nerve	20 (.14%)
Neurological Disorders Congenital	20 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Lidoderm, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lidoderm is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.